Simple tool to detect early decompensated heart failure in people 55+ on Réunion Island
Official title: The Value of a Simple Tool for the Early Detection of Decompensated Heart Failure in People Over 55 on Réunion Island: A Preliminary Study in Hospitals (DEPIST'IC-RUN)
Run by Centre Hospitalier Universitaire de la Réunion · NCT07673562 · Data updated 2026-11-12
A quick questionnaire-based screening tool is tested in adults 55 and older admitted to cardiology units in Réunion to see if it can identify decompensated heart failure early.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 55 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Centre Hospitalier Universitaire de la Réunion Academic / other |
| Locations | 3 sites (Saint-Denis, Reunion and 2 other locations) |
| Status | Recruiting |
| Started | August 1, 2026 |
| Main results expected | February 2027 |
| Study ends | February 2027 |
| Registry record updated | September 23, 2026 |
| Trial ID | NCT07673562 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 55 and older, resident of Réunion, admitted unscheduled to cardiology units, able to read and write French, and enrolled in a social security program.
✕Probably not a fit
Patients with solidly ruled-out heart failure by gold standard testing or those not meeting language or consent criteria may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a cross-sectional diagnostic study conducted in two Réunion hospitals. It tests a simple, rapid screening questionnaire against the standard diagnostic approach to detect decompensated heart failure. The study unfolds in two phases: first developing the tool using expert consensus, then applying the tool at patient admission and comparing results to the gold standard. Participants are adults 55 and older, residents of Réunion, admitted on an unscheduled basis to cardiology units, and able to communicate in French. Data collection is prospective and does not alter standard of care.
Why it matters
Potential benefit: If successful, the tool could help clinicians quickly identify patients with a high probability of decompensated heart failure at admission.
How similar studies have gone: Previous work on screening questionnaires for heart failure has shown mixed but promising results in enabling earlier recognition.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients: * Aged 55 and older * Admitted on an unscheduled basis to the cardiology department at the CHU (North and South campuses) and the CHOR for any reason (in general wards or intensive care) * Residents of Réunion * Able to read and write French * Enrolled in a social security program * Willing to participate in the study Exclusion Criteria: Patients: * Who cannot communicate in French * For whom it is impossible to administer the questionnaire * For whom the ETT and/or cardiology consultation are impossible * Who are under guardianship, conservatorship, or judicial protection
Where it's running
-
CHU Réunion - NORD
Saint-Denis, Reunion, Reunion Recruiting -
Chor
Saint-Paul, Reunion, Reunion Not yet recruiting -
CHU Réunion- SUD
Saint-Pierre, Reunion, Reunion Not yet recruiting
Study contacts
- Study coordinator: Jérôme CORRE, Dr
- Email: jerome.corre@chu-reunion.fr
- Phone: +262 262 90 05 52
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.